miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice
Regulus Therapeutics (United States) · California Institute of Technology · +1 more institution
Abstract
Excessive or inappropriate activation of the immune system can be deleterious to the organism, warranting multiple molecular mechanisms to control and properly terminate immune responses. MicroRNAs (miRNAs), ∼22-nt-long noncoding RNAs, have recently emerged as key posttranscriptional regulators, controlling diverse biological processes, including responses to non-self. In this study, we examine the biological role of miR-146a using genetically engineered mice and show that targeted deletion of this gene, whose expression is strongly up-regulated after immune cell maturation and/or activation, results in several immune defects. Collectively, our findings suggest that miR-146a plays a key role as a molecular…
Citation impact
- FWCI
- 25.86
- Percentile
- 100%
- References
- 53
Authors
14- MBMark BoldinCorresponding
Regulus Therapeutics (United States), California Institute of Technology
- KDKonstantin D. Taganov
Regulus Therapeutics (United States), California Institute of Technology
- DSDinesh S. Rao
California Institute of Technology, University of California, Los Angeles
- LYLili Yang
California Institute of Technology
- JLJimmy L. Zhao
California Institute of Technology
Topics & keywords
- Immune system
- Biology
- microRNA
- Autoimmunity
- Inflammation
- Immunology
- Cancer
- Gene
- Good health and well-being